Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2318 (LINC02318) is a member of the long intergenic non-coding RNA (lincRNA) family, a subclass of long non-coding RNAs, which are transcripts over 200 nucleotides in length that do not encode proteins and do not overlap annotated protein-coding genes[1][3][5]. LINC02318 is encoded in the human genome and transcribed into RNA, but its specific biological function and involvement in human diseases remain poorly characterized[1]. In general, lincRNAs are thought to contribute to gene regulation at multiple levels, including chromatin remodeling, transcription, and mRNA processing, and they may act in *cis* (affecting neighboring genes) or *trans* (acting distantly)[3][5]. While some lincRNAs play defined roles in cell biology and disease, there is currently no direct evidence linking LINC02318 to a specified molecular pathway, disease, biomarker role, or therapeutic interaction[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2318 (LINC02318).